Nalbuphine Hydrochloride Injection, Solution
Product Images NDC 0409-1467

11 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 0409-1467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Nalbuphine 01)

FDA Label Image

Chemical Structure (Nalbuphine 02)

Chemical Structure (Nalbuphine 02)
Chemical structure of Nalbuphine Hydrochloride showing its molecular framework with hydroxyl groups, a cyclobutylmethyl group attached to the nitrogen, and the hydrochloride salt indicated.*
FDA Label Image

Logo (Nalbuphine 03)

FDA Label Image

Principal Display Panel (1 mL Ampule Label)

Principal Display Panel (1 mL Ampule Label)
Nalbuphine Hydrochloride Injection 10 mg/mL label showing vial volume of 1 mL. Label indicates use for intravenous, intramuscular, or subcutaneous injection, and protection from light. Distributed by Hospira, Inc., Lake Forest, IL, USA. Includes lot number and expiration date placeholders, plus a barcode.*
FDA Label Image

Principal Display Panel (1 mL Ampule Tray Label)

Principal Display Panel (1 mL Ampule Tray Label)
Nalbuphine Hydrochloride Injection 10 mg/mL label for 1 mL single-dose ampuls, pack of 10, by Hospira, Inc. The label states it is for intravenous, intramuscular, or subcutaneous use. It includes buffering agents, storage instructions, and a note to protect from light and keep ampuls in tray until use. The NDC codes 0409-1463-01 and 0409-1463-71 are visible.*
FDA Label Image

Principal Display Panel (1 mL Ampule Label)

Principal Display Panel (1 mL Ampule Label)
Nalbuphine Hydrochloride Injection 20 mg/mL vial label. The label states the drug is for intravenous, intramuscular, or subcutaneous use and should be protected from light. The product is distributed by Hospira, Inc., Lake Forest, Illinois, USA. The label includes the National Drug Code (NDC) 0409-1465-71 and indicates the vial size as 1 mL.*
FDA Label Image

Principal Display Panel (1 mL Ampule Tray Label)

Principal Display Panel (1 mL Ampule Tray Label)
Nalbuphine Hydrochloride Injection 20 mg/mL label for single-dose 1 mL ampuls, packaged in sets of 10. The label states it is for intravenous, intramuscular, or subcutaneous use. It includes dosage form and strength, use instructions, storage conditions, and is distributed by Hospira, Inc. The label also contains a barcode and a lot and expiration date placeholder.*
FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Nalbuphine Hydrochloride Injection 100 mg/10 mL (10 mg/mL) vial label, multiple-dose, 10 mL volume. The label includes product identification, usage instructions for intravenous, intramuscular, or subcutaneous use, and storage instructions. It is distributed by Hospira, Inc., Lake Forest, IL. Additional text details composition and handling including preservation and sterility.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
Packaging label for Nalbuphine Hydrochloride Injection 100 mg/10 mL (10 mg/mL) multiple-dose fliptop vial distributed by Hospira, Inc. The label includes lot and expiration date placeholders, barcode, usage instructions, storage conditions, and preservative information. The product is for intravenous, intramuscular, or subcutaneous use.*
FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Nalbuphine Hydrochloride Injection 200 mg/10 mL (20 mg/mL) multi-dose vial label. The label indicates use for intravenous, intramuscular, or subcutaneous administration and includes storage and handling instructions. Distributed by Hospira, Inc., Lake Forest, IL. The label also displays the NDC code 0409-1467-61 and batch and expiration date placeholders.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
Packaging label for Nalbuphine Hydrochloride Injection 200 mg/10 mL (20 mg/mL) by Hospira, Inc. The multi-dose flipt-top vial contains 10 mL. Label instructions include protection from light, routes of administration (intravenous, intramuscular, subcutaneous), storage temperature, and aseptic technique use. Contains a lot number and expiration date area, along with barcode and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.